Risk Assessment-Based Enhanced Analytical Quality by Design Approach to Eco-Friendly and Economical Multicomponent Spectrophotometric Methods for Simultaneous Estimation of Montelukast Sodium and Bilastine.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of AOAC International"
DOI: 10.1093/jaoacint/qsab089
Abstract: BACKGROUND The concomitant montelukast and bilastine are used as additive therapy for seasonal allergic rhinoconjuctivitis and mild to moderate asthma. According to the literature review, no UV-visible spectrophotometry method has been reported yet for simultaneous… read more here.
Keywords: montelukast sodium; estimation; bilastine; sodium bilastine ... See more keywords
Quality of life in patients with allergic rhinitis: a clinical trial comparing the use of bilastine versus loratadine
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Otolaryngology"
DOI: 10.1111/coa.12695
Abstract: The aim of this study was to determine whether there were differences in health‐related quality of life of patients with allergic rhinitis treated with bilastine 20 mg compared to those treated with loratadine 10 mg. read more here.
Keywords: allergic rhinitis; life patients; bilastine; quality life ... See more keywords
Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study
Sign Up to like & getrecommendations! Published in 2022 at "International Archives of Allergy and Immunology"
DOI: 10.1159/000524856
Abstract: Introduction: The aim of this study was to compare the pharmacodynamic activity of bilastine administered under fasting and fed conditions in healthy volunteers. Methods: In this randomized, open-label, two-period, crossover study involving 24 healthy subjects,… read more here.
Keywords: day; food; wheal flare; bilastine ... See more keywords
The safety and tolerability profile of bilastine for chronic urticaria in children
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Translational Allergy"
DOI: 10.1186/s13601-019-0294-3
Abstract: BackgroundUrticaria is a condition defined by the development of wheals, angioedema or both. It is classified based on its duration as acute (≤ 6 weeks) or chronic (> 6 weeks). Chronic urticaria is less frequent than acute one in… read more here.
Keywords: tolerability profile; safety tolerability; tolerability; bilastine ... See more keywords
Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
Sign Up to like & getrecommendations! Published in 2018 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2018.39.4136
Abstract: BACKGROUND Bilastine is an H1-antihistamine approved for symptomatic treatment of patients with allergic rhinoconjunctivitis or urticaria. The safety profile of bilastine in clinical trials of allergic rhinoconjunctivitis or urticaria, assessed by type and frequency of… read more here.
Keywords: safety profile; safety; bilastine; rhinoconjunctivitis urticaria ... See more keywords